NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Morphotek Inc. 

210 Welsh Pool Road

Exton  Pennsylvania  19341  U.S.A.
Phone: 610-423-6100 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Morphotek Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody 10/28/2009 7:00:42 AM    More...
Morphotek Inc.: Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects 9/24/2009 8:55:36 AM    More...
Morphotek Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins 9/23/2009 11:38:23 AM    More...
Morphotek Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 7/15/2009 9:56:32 AM    More...
Morphotek Inc. Announces a Research Collaboration Agreement with Synageva BioPharma to Develop Potential Treatments for Cancer and Infectious Disease 7/1/2009 7:16:00 AM    More...
Morphotek Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors 6/9/2009 10:02:51 AM    More...
Morphotek Inc. and Lonza Group Ltd. Enter Into Manufacturing Services Agreement 5/19/2009 11:25:07 AM    More...
Human Genome Sciences, Inc. (HGSI) and Morphotek Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology 3/25/2009 7:28:13 AM    More...
Morphotek Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3/23/2009 7:29:44 AM    More...
Morphotek Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3/2/2009 10:23:07 AM    More...
12345678